{
    "nctId": "NCT04468867",
    "briefTitle": "Role of ABUS as an Alternative to Breast MRI in Assessing Response to Neoadjuvant Chemotherapy",
    "officialTitle": "Role of ABUS as an Alternative to Breast MRI in Assessing Response to Neoadjuvant Chemotherapy",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Tumour size",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. All female participants eligible for neoadjuvant chemotherapy and planning surgical treatment\n2. Able to give informed consent\n\nExclusion Criteria:\n\n1. All female particpants having neoadjuvant chemotherapy as palliative treatment with no surgery planned\n2. Unable to provide informed consent\n3. Unable to have breast MRI scan due to clautrophobia or allergy to gadolineum",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}